Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services is recalling Omeprazole/Sodium Bicarbonate capsules because they may be mislabeled as Cyanocobalamin or Omega-3 fatty acid products.
Aidapak Services is recalling Calcium Citrate tablets that may be mislabeled as Tizanidine HCl. The error could lead to patients taking the wrong medication.
Aidapak Services, LLC is recalling Quetiapine Fumarate 25 mg tablets because they may be mislabeled as Chlordiazepoxide HCl capsules.
Aidapak Services, LLC is recalling Itraconazole capsules because they may be mislabeled as Famciclovir tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling 402 Metoprolol Tartrate tablets because they may be mislabeled as Docusate Sodium capsules.
Aidapak Services, LLC is recalling D-Alpha Tocopheryl Acetate capsules because they may be mislabeled as Cyanocobalamin tablets.
Aidapak Services, LLC is recalling Metoprolol Succinate ER 200 mg tablets due to a potential labeling mixup. The affected repacked drugs were distributed in four western states.
Aidapak Services is recalling Omeprazole/Sodium Bicarbonate capsules because they may be mislabeled as Benzocaine/Menthol lozenges. The FDA classifies this as a Class II recall.
Aidapak Services, LLC is recalling Hydralazine HCL 25 mg tablets because they may be mislabeled as Docusate Calcium 240 mg capsules.
Aidapak Services is recalling Rifaximin 200 mg tablets that may be mislabeled as Toprol 25 mg. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Quetiapine Fumarate 25 mg tablets because they may be mislabeled as multivitamin or aspirin products.
Aidapak Services is recalling Solifenacin Succinate 5 mg tablets because they may be mislabeled as Bromocriptine Mesylate 2.5 mg.
Aidapak Services, LLC is recalling Benzoicaine/Menthol lozenges because they may be mislabeled as Cholecalciferol/Calcium/Phosphorus tablets.
Aidapak Services, LLC is recalling specific lots of Colchicine 0.6 mg tablets because they may be mislabeled as other medications.
Aidapak Services is recalling Galantamine HBr ER capsules because they may be mislabeled as Famotidine tablets.
The Anspach Effort, Inc. is recalling all lots of MCA Cutting Burrs and Dissection Tools because the indications for use were broader than validated and directions were unclear.
Aidapak Services, LLC is recalling Pseudoephedrine HCL 60 mg tablets because they may be mislabeled as Repaglinide 1 mg tablets.
Pfizer is recalling specific lots of Zithromax (azithromycin) injection due to out-of-specification results for a degradant.
Aidapak Services, LLC is recalling Allopurinol 300 mg tablets because they may be mislabeled as Cholecalciferol 400 units.
Aidapak Services is recalling RANOLAZINE ER 500 mg tablets because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.
The Anspach Effort, Inc. is recalling all lots of MCA Cutting Burrs and Dissection Tools because the indications for use were broader than the device's validation.
Aidapak Services is recalling diphenhydramine HCl tablets because they may be mislabeled as atorvastatin, prenatal vitamins, or venlafaxine.
Aidapak Services is recalling Olanzapine 7.5 mg tablets due to a potential labeling mixup with Nortriptyline HCL capsules.
Aidapak Services, LLC is recalling 1 mg Melatonin tablets that may be mislabeled as Omega-3 fatty acid capsules. The error involves a potential mix-up between two different products.
Aidapak Services, LLC is recalling 229 capsules of carbamazepine ER 200 mg due to a labeling mixup where the product may be mislabeled as acamprosate calcium.